MindWalk Holdings (HYFT) Exchange Rate Effect (2023 - 2026)
MindWalk Holdings (HYFT) reported Exchange Rate Effect of -$276698.8 for Q1 2026, down 186.71% year-over-year from $319105.4 in Q1 2025, and down 129.84% quarter-over-quarter from -$120386.8 in Q4 2025.
MindWalk Holdings (HYFT) Exchange Rate Effect (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 4 years of Exchange Rate Effect data on file, last reported at -$276698.8 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$276698.8, down 186.71% year-over-year; the trailing twelve-month figure through Jan 2026 was $311.0 million (up 170323.23% YoY), and the FY2025 annual result was -$426.43, down 100.67% from the prior year.
- Exchange Rate Effect retreated to -$276698.8 in Q1 2026 per HYFT's latest filing, from -$120386.8 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $311.3 million in Q2 2025 and troughed at -$357699.8 in Q2 2023.
- A 4-year average of $23.9 million and a median of -$23600.6 in 2024 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 1319168.86% in 2025 and fell as far as 78759.33% in 2025.
- A 4-year view of Exchange Rate Effect shows it stood at -$50887.1 in 2023, then jumped by 100.3% to $153.05 in 2024, then slumped by 78759.33% to -$120386.8 in 2025, then sank by 129.84% to -$276698.8 in 2026.
- Business Quant data shows HYFT's Exchange Rate Effect at -$276698.8 in Q1 2026, -$120386.8 in Q4 2025, and $41483.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -276,698.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -276,698.76 |
| Jan 31, 2026 | -276,698.76 |
| Oct 31, 2025 | -120,386.79 |
| Oct 31, 2025 | -120,386.79 |
| Jul 31, 2025 | 41,483.76 |
| Jul 31, 2025 | 41,483.76 |
| Apr 30, 2025 | 311.31 Mn |
| Apr 30, 2025 | 311.31 Mn |
| Jan 31, 2025 | 319,105.36 |
| Jan 31, 2025 | 319,105.36 |
| Oct 31, 2024 | 153.05 |
| Oct 31, 2024 | 153.05 |
| Jul 31, 2024 | -113,198.36 |
| Jul 31, 2024 | -113,198.36 |
| Apr 30, 2024 | -23,600.65 |
| Apr 30, 2024 | -23,600.65 |
| Jan 31, 2024 | 432,737.06 |
| Jan 31, 2024 | 432,737.06 |
| Oct 31, 2023 | -50,887.08 |
| Oct 31, 2023 | -50,887.08 |